PLAY PODCASTS
Long-Acting ART: Lenacapavir
Episode 259

Long-Acting ART: Lenacapavir

Listen to Darcy Wooten, MD, discuss the long-acting HIV treatment agent lenacapavir for treatment-experienced PWH, including efficacy data, initiation strategies, virologic failure data, and safety information.

Decera Clinical Education Infectious Disease Podcast · Darcy Wooten MD

March 3, 20235m 51s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Darcey Wooten, MD, discusses the long-acting HIV treatment agent lenacapavir for treatment-experienced people with HIV, including:

  • Efficacy data
  • Initiation strategies
  • Virologic failure data
  • Safety information

Presenter:

Darcy Wooten, MD
Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
San Diego, California

To download the slides:
http://bit.ly/3Jb1ofX

To view the full online program:
https://bit.ly/3ZjSFhg


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

resistance mutationspeople with hivlong-acting artlenacapavir dosingla artcalibratelenacapavirlenacapavir maintenanceobrlong-acting antiretroviral therapylenacapavir initiationoptimized background regimenlong-acting injectablecapellavirologic failurelenefficacyla injectablehivpwhinjection site reactions